Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Pulmonx Corp

NASDAQ: LUNG · Industrial Applications and Services · 2 alerts · CIK 1127537

Share price
$2.80Close, Nov 16
Market cap
$122M
Shares outstanding
43.55MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Pulmonx Corp filings on SEC EDGAR ↗

4:40 PM ET 10-Q
Financial Results

Pulmonx Q3 2026 Results: Net Loss of $8.39M, Loss Narrows

Pulmonx Corp reported revenue of $22.8 million for the third quarter of 2026, a slight increase from $21.5 million in the prior year period. The company significantly reduced its net loss to $8.4 million for the quarter compared to $14.0 million in Q3 2025, primarily driven by a reduction in selling, general, and administrative expenses.

Key figure
Net loss $8.39M
4:08 PM ET 8-K
Financial Results

Pulmonx Financial Results

Pulmonx reported Q3 2026 worldwide revenue of $22.8 million, a 6% increase year-over-year, driven by 7% growth in the U.S. market. The company significantly reduced its net loss by 40% to $8.4 million and its Adjusted EBITDA loss by 57% through cost realignment efforts while maintaining a strong gross margin of 76%.

Term
Q3 2026

“We are very pleased to have returned to year-over-year revenue growth in the third quarter. We continue to execute on our commercial strategy, advance our clinical initiatives, and deliver the operating leverage we expected.”

Glen French, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.